774 related articles for article (PubMed ID: 14633667)
1. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.
Fang MZ; Wang Y; Ai N; Hou Z; Sun Y; Lu H; Welsh W; Yang CS
Cancer Res; 2003 Nov; 63(22):7563-70. PubMed ID: 14633667
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate reverses the expression of various tumor-suppressor genes by inhibiting DNA methyltransferases and histone deacetylases in human cervical cancer cells.
Khan MA; Hussain A; Sundaram MK; Alalami U; Gunasekera D; Ramesh L; Hamza A; Quraishi U
Oncol Rep; 2015 Apr; 33(4):1976-84. PubMed ID: 25682960
[TBL] [Abstract][Full Text] [Related]
3. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.
Fang MZ; Chen D; Sun Y; Jin Z; Christman JK; Yang CS
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):7033-41. PubMed ID: 16203797
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines.
Fang MZ; Jin Z; Wang Y; Liao J; Yang GY; Wang LD; Yang CS
Int J Oncol; 2005 Mar; 26(3):615-22. PubMed ID: 15703815
[TBL] [Abstract][Full Text] [Related]
5. Dietary polyphenols may affect DNA methylation.
Fang M; Chen D; Yang CS
J Nutr; 2007 Jan; 137(1 Suppl):223S-228S. PubMed ID: 17182830
[TBL] [Abstract][Full Text] [Related]
6. Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells.
Morris J; Moseley VR; Cabang AB; Coleman K; Wei W; Garrett-Mayer E; Wargovich MJ
Oncotarget; 2016 Jun; 7(23):35313-26. PubMed ID: 27167203
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide inhibits DNA methyltransferase and restores methylation-silenced genes in human liver cancer cells.
Cui X; Wakai T; Shirai Y; Yokoyama N; Hatakeyama K; Hirano S
Hum Pathol; 2006 Mar; 37(3):298-311. PubMed ID: 16613325
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate inhibits homocysteine-induced apoptosis of endothelial cells by demethylation of the DDAH2 gene.
Zhang BK; Lai YQ; Niu PP; Zhao M; Jia SJ
Planta Med; 2013 Dec; 79(18):1715-9. PubMed ID: 24243545
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids.
Lee WJ; Shim JY; Zhu BT
Mol Pharmacol; 2005 Oct; 68(4):1018-30. PubMed ID: 16037419
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.
Nandakumar V; Vaid M; Katiyar SK
Carcinogenesis; 2011 Apr; 32(4):537-44. PubMed ID: 21209038
[TBL] [Abstract][Full Text] [Related]
11. Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells.
Gao Z; Xu Z; Hung MS; Lin YC; Wang T; Gong M; Zhi X; Jablon DM; You L
Anticancer Res; 2009 Jun; 29(6):2025-30. PubMed ID: 19528461
[TBL] [Abstract][Full Text] [Related]
12. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
Gu B; Ding Q; Xia G; Fang Z
Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma.
Viswanathan M; Tsuchida N; Shanmugam G
Int J Cancer; 2003 May; 105(1):41-6. PubMed ID: 12672028
[TBL] [Abstract][Full Text] [Related]
14. The Inhibitory Effect of (-)-Epigallocatechin-3-Gallate on Breast Cancer Progression via Reducing
Sheng J; Shi W; Guo H; Long W; Wang Y; Qi J; Liu J; Xu Y
Molecules; 2019 Aug; 24(16):. PubMed ID: 31404982
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation status of the DNA repair genes hMLH1 and MGMT in gastric carcinoma and metaplastic mucosa.
Oue N; Sentani K; Yokozaki H; Kitadai Y; Ito R; Yasui W
Pathobiology; 2001; 69(3):143-9. PubMed ID: 11872960
[TBL] [Abstract][Full Text] [Related]
16. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas.
Ye C; Shrubsole MJ; Cai Q; Ness R; Grady WM; Smalley W; Cai H; Washington K; Zheng W
Oncol Rep; 2006 Aug; 16(2):429-35. PubMed ID: 16820927
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
[TBL] [Abstract][Full Text] [Related]
19. Accumulation of promoter methylation suggests epigenetic progression in squamous cell carcinoma of the esophagus.
Guo M; Ren J; House MG; Qi Y; Brock MV; Herman JG
Clin Cancer Res; 2006 Aug; 12(15):4515-22. PubMed ID: 16899597
[TBL] [Abstract][Full Text] [Related]
20. Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
Fox EJ; Leahy DT; Geraghty R; Mulcahy HE; Fennelly D; Hyland JM; O'Donoghue DP; Sheahan K
J Mol Diagn; 2006 Feb; 8(1):68-75. PubMed ID: 16436636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]